豪悅護理(605009.SH):擬對江蘇豪悅增資1.2億元
格隆匯12月27日丨豪悅護理(605009.SH)公佈,公司於2021年12月27日召開第二屆董事會第十二次會議,審議通過《關於向全資子公司追加投資的議案》。根據全資子公司江蘇豪悅實業有限公司(“江蘇豪悅”)實際經營及業務發展需要,公司擬以自有資金對其進行增資,本次增資1.2億元。
增資後,公司持股比例仍爲100%,子公司股權結構維持不變,其註冊資本由1億元變爲2.2億元。同時,提請董事會授權董事長及其授權的指定人員全權辦理本次增資具體事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.